The distribution of MG in CLL and its relationship to IGHV gene. (A) Distribution of different subtypes of MG. (B) The distribution of lambda and kappa light-chain use in different types of paraproteinemia. (C) Proportion of patients with mutated IGHV in different MG group. (D) Relationship between MG subtypes and IGHV mutational status. (E) The distribution of IGHV segment use in patients with or without MG.